Patents by Inventor Aron Charles Eklund

Aron Charles Eklund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10577662
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: March 3, 2020
    Assignees: Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation, The Technical University of Denmark
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • Publication number: 20170342500
    Abstract: The invention relates to a method for predicting the localization of a primary tumour, wherein said method comprises the use of genomic profile data, and wherein the method is capable of predicting the type of cancer by a classification score ranking among a variety of the possible tumour types.
    Type: Application
    Filed: December 18, 2015
    Publication date: November 30, 2017
    Inventors: Andrea Marion Marquard, Aron Charles Eklund, Nicolai Juul Birkbak, Zoltan Imre Szallasi
  • Publication number: 20170037478
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC., CHILDREN'S MEDICAL CENTER CORPORATION, THE TECHNICAL UNIVERSITY OF DENMARK
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • Patent number: 9512485
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: December 6, 2016
    Assignees: Dana-Farber Cancer Institute. Inc., The Brigham and Women's Hospital. Inc., Children's Medical Center Corporation, The Technical University of Denmark
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • Publication number: 20130281312
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: August 19, 2011
    Publication date: October 24, 2013
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., THE TECHNICAL UNIVERSITY OF DENMARK, CHILDREN'S MEDICAL CENTER CORPORATION, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Andrea L. Richardson, Zhingang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund